Table 1 Patient characteristics and EpCAM Protein Expression by Flow Cytometry and by qReal-Time PCR in carcinosarcoma cell lines
Cell Line | Histology | Age | Race | FIGO Stage | Primary site | Percentage EpCAM-Positive Cells | MFI | Avg dCt qReal-Time PCR | |
|---|---|---|---|---|---|---|---|---|---|
ES | SC | ||||||||
SARARK-1 | Homologous | ESS | 70 | AA* | IC | Uterus | 10.6 | 13.2 | 17.87 |
END + CC | |||||||||
SARARK-3 | Heterologous | CDRS | 75 | C | IIIC | Ovary | 100 | 726 | 3.84 |
SER | |||||||||
SARARK-6 | Homologous | CDR | 78 | C | IV/IIB | Ovary | 100 | 301.2 | 3.57 |
SER | |||||||||
SARARK-7 | Heterologous | CDRS | 55 | AA | IV | Ovary | 100 | 939.9 | 7.16 |
CC + SER | |||||||||
SARARK-9 | Homologous | ESS | 66 | C | IIIC2 | Uterus | 100 | 862.6 | 6.05 |
SER |